By Associate Professor Behzad Hajarizadeh

Book Chapters

Hajarizadeh B; Martinello M; Dore G, 2021, 'HCV Elimination in Australia', in Hepatitis C: Epidemiology, Prevention and Elimination Volume 1, Springer, https://doi.org/10.1007/978-3-030-64649-3_11

Martinello M; Hajarizadeh B; Grebely J; Matthews G; Dore G, 2019, 'Cure and Control: What Will It Take to Eliminate HCV?', in Sofia M (ed.), HCV: The Journey from Discovery to a Cure: Volume II, Springer International Publishing, pp. 447 - 490, http://dx.doi.org/10.1007/7355_2018_56

Journal articles

Kronfli N; Popovic N; Weiss E; Stoové M; Lafferty L; Price O; Madden LM; Hajarizadeh B; Lloyd AR; Altice FL, 2026, 'Gatekeeping harm reduction in Canadian Federal Prisons: Perspectives on the threat risk assessment for the prison needle exchange program by prison administrative leadership', Addiction, 121, pp. 2091 - 2103, http://dx.doi.org/10.1111/add.70376

Blackmore C; Lockart I; Gandy G; Yeoh YKJ; Flynn C; Prince DS; Dore G; Danta M; George J; Alavi M; Farooque Y; Hajarizadeh B; Levy MT, 2026, 'Recurrence after surgery for hepatocellular carcinoma: “The seed and the soil” - a multicentre retrospective cohort study', World Journal of Hepatology, 18, http://dx.doi.org/10.4254/wjh.120213

Price O; Altice FL; Madden LM; Taljaard M; Stoové M; Hajarizadeh B; Lafferty L; Kronfli N, 2026, 'Enhancing uptake of the Canadian Prison Needle Exchange Program using a non-randomized stepped-wedge cluster type 1 hybrid implementation trial: The NEXUS study protocol', Contemporary Clinical Trials Communications, 51, http://dx.doi.org/10.1016/j.conctc.2026.101642

Conway A; Grebely J; Tillakeratne S; Cunningham EB; Munyengeterwa U; Van Dyk J; Martinello M; Carson J; Lafferty L; Bull RA; Horsburgh B; McGrath C; Brown T; Treloar C; Amin J; Degenhardt L; Applegate TL; Dunlop A; Matthews GV; Dore GJ; Lloyd AR; Hajarizadeh B, 2026, 'Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study', International Journal of Drug Policy, 151, http://dx.doi.org/10.1016/j.drugpo.2026.105234

Santo T; Hickman M; Altice FL; Grebely J; Taylor S; Lynch M; Kamenjaš A; Marsden J; Tran LT; Webb P; Price O; Macdonald C; Montanari L; Royuela L; Busse A; Stone J; da Costa FA; Berk J; Daniels C; Cunningham E; Vickerman P; Hajarizadeh B; Sabin K; Verster A; Farrell M; Degenhardt L, 2026, 'Global coverage of interventions for reduction of injecting drug use-related harm, HIV, viral hepatitis and tuberculosis in prisons and other carceral settings: A systematic review', International Journal of Drug Policy, 150, http://dx.doi.org/10.1016/j.drugpo.2025.105069

Lafferty L; Popovic N; Weiss E; Hajarizadeh B; Lloyd AR; Altice FL; Kronfli N, 2026, 'Navigating harm reduction and security mandates: Prison leadership perspectives on implementing prison needle exchange programs in Canada', International Journal of Drug Policy, 150, http://dx.doi.org/10.1016/j.drugpo.2026.105197

Degenhardt L; Hickman M; Altice FL; Grebely J; Taylor S; Lynch M; Kamenjaš A; Marsden J; Tran LT; Webb P; Price O; Macdonald C; da Costa FA; Berk J; Busse A; Cunningham E; Daniels C; Hajarizadeh B; Montanari L; Royuela L; Sabin K; Stone J; Verster A; Vickerman P; Farrell M; Santo T, 2026, 'The global epidemiology of injecting drug use, HIV, viral hepatitis and tuberculosis among people who are incarcerated: a multistage systematic review', International Journal of Drug Policy, 150, http://dx.doi.org/10.1016/j.drugpo.2025.105062

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Roth M; Willing AR; Sazzad HMS; Marshall AD; Fontaine G; Conway A; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Lafferty L; Lloyd A; Sheehan Y; Akiyama MJ; Kronfli N; Cabezas J; Grebely J, 2026, 'Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis', International Journal of Drug Policy, 149, http://dx.doi.org/10.1016/j.drugpo.2025.105082

Hajarizadeh B; George J; Levy MT; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate TL; Matthews GV, 2026, 'Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study', Journal of Clinical Microbiology, 64, http://dx.doi.org/10.1128/jcm.01405-25

Montague C; Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study', International Journal of Drug Policy, 146, http://dx.doi.org/10.1016/j.drugpo.2025.105035

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2025, 'Using the socioecological model to guide service delivery improvements to the prison needle exchange program in Canada: insights from multi-level stakeholders', BMC Public Health, 25, http://dx.doi.org/10.1186/s12889-025-24935-y

George J; Allard NL; Roberts SK; Adams LA; Davies J; Hajarizadeh B; MacLachlan JH; Mahady SE; Altus R; Brown C; Fry DC; Greenwood-Smith B; Smud N; Valery PC; Yussf N; Broun K; Campbell D; Canfell K; Harrison CC; Freeman V; Grogan P; Holliday C; Hughes S; Kelly A; van Kemenade C; Latumahina C; McAtamney A; Varlow M; Worthington J; Yuill S; Feletto E, 2025, 'Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations', Medical Journal of Australia, 223, pp. 426 - 436, http://dx.doi.org/10.5694/mja2.70061

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, 144, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Razavi HA; Waked I; Qureshi H; Kondili LA; Duberg AS; Aleman S; Tanaka J; Lazarus JV; Low-Beer D; Abbas Z; Rached AA; Aghemo A; Aho I; Akarca US; Al-Busafi SA; Al-Hamoudi WK; Al-Naamani K; Alaama AS; Aldar MM; Alghamdi M; Gonzalez MA; Alserehi H; Anand AC; Asselah T; Assiri AM; Athanasakis K; Atugonza R; Ben-Ari Z; Berg T; Brandão-Mello CE; Brown ASM; Brown KA; Brown RS; Bruggmann P; Brunetto MR; Buti M; Cheinquer H; Christensen PB; Chulanov V; Cisneros Garza LE; Coffin CS; Coppola N; Craxi A; Crespo J; Cui F; Dalgard O; De La Torre A; De Ledinghen V; Dieterich D; Drazilova S; Dufour JF; El-Kassas M; Elbadri M; Esmat G; Mur RE; Eurich B; Faini D; Ferreira PRA; Flisiak R; Frankova S; Gaeta GB; Gamkrelidze I; Gane EJ; Garcia V; García-Samaniego J; Gemilyan M; Gottfredsson M; Gschwantler M; Gurski APM; Hajarizadeh B; Hamid SS; Hatzakis A; Hercun J; Hockicková I; Huang JF; Hunyady B; Hutchinson SJ; Ishikawa N; Izumi K; Izzi A; Janicko M; Jarcuska P; Jeruma A; Johannessen A; Kaliaskarova KS; Kao JH; Kielland KB; Kodjoh N; Kottilil S; Kristian P; Kwo PY; Lagging M; Lam H; Lázaro P; Lee MH; Lens S; Liakina V; Lim YS; Makara M; Manns M, 2025, 'Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies', Journal of Hepatology, 83, pp. 329 - 347, http://dx.doi.org/10.1016/j.jhep.2025.01.013

Legrand NM; Bull RA; Hajarizadeh B; Lloyd AR; Johnston K; Issa K; Harvey C; Arnott A; Dwyer DE; Sintchenko V; Grant L; Dore GJ; Kaldor J; Martinello M, 2025, 'Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia', Emerging Infectious Diseases, 31, pp. 1527 - 1536, http://dx.doi.org/10.3201/eid3108.240571

Hiebert-Suwondo L; Manning J; Tohme RA; Buti M; Kondili LA; Spearman CW; Prabdial-Sing N; Turnier V; Lazarus JV; Waked I; Ward JW; Miranda A; Sugiyama A; Hajarizadeh B; Varaldo C; Thomas C; Muñoz C; Leeman D; Dore G; Desalegn H; Aberra H; Cheinquer H; Qureshi H; Ivanchuk I; Grebely J; García-Samaniego J; Tanaka J; Tint KS; Poovorawan K; De Feo ME; Sonderup M; Aleksandrova M; Ali M; Hassany M; Marinho R; Hamid S; Punpetch S; Naing TS; Tanaka-Kumadai Y; Lim YS; Nartey Y, 2025, 'A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles', Lancet Gastroenterology and Hepatology, 10, pp. 671 - 684, http://dx.doi.org/10.1016/S2468-1253(25)00069-X

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Hiebert-Suwondo L; Manning J; Tohme RA; Buti M; Kondili LA; Spearman CW; Hajarizadeh B; Turnier V; Lazarus JV; Grebely J; Dore GJ; Waked ; Ward JW; Collaborators HEP; Miranda A; Sugiyama A; Varaldo C; Thomas C; Muñoz C; Desalegn H; Aberra H; Cheinquer H; Qureshi H; Ivanchuk I; García-Samaniego J; Tanaka J; San Tint K; Poovorawan K; De Feo ME; Sonderup M; Aleksandrova M; Ali M; Hassany M; Desai M; Prabdial-Sing N; Marinho R; Hamid S; Punpetch S; Naing TS; Tanaka-Kumadai Y; Lim Y-S; Nartey Y, 2025, 'A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles', The Lancet Gastroenterology & Hepatology, 10, pp. 685 - 700, http://dx.doi.org/10.1016/s2468-1253(25)00068-8

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Macdonald C; Macpherson G; Leppan O; Tran LT; Cunningham EB; Hajarizadeh B; Grebely J; Farrell M; Altice FL; Degenhardt L, 2024, 'Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis', Lancet Public Health, 9, pp. e684 - e699, http://dx.doi.org/10.1016/S2468-2667(24)00160-9

Lafferty L; Altice FL; Leone F; Stoové M; Lloyd AR; Hajarizadeh B; Kronfli N, 2024, 'Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104549

Elliott S; Flynn E; Mathew S; Hajarizadeh B; Martinello M; Wand H; Ward J, 2024, 'Prevalence of hepatitis C virus exposure and infection among Indigenous and tribal populations: a global systematic review and meta-analysis', Public Health, 233, pp. 65 - 73, http://dx.doi.org/10.1016/j.puhe.2024.04.035

Kronfli N; Lafferty L; Leone F; Stoové M; Hajarizadeh B; Lloyd AR; Altice FL, 2024, 'Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers', International Journal of Drug Policy, 130, http://dx.doi.org/10.1016/j.drugpo.2024.104540

Griffin S; Lee Wilkinson A; Winter R; Hajarizadeh B; MacIsaac M; Papaluca T; Holmes J; Lloyd AR; Carson J; Craigie A; Hellard M; Stoové M; Thompson A, 2024, 'Contribution of prison-based hepatitis C treatment initiations to overall treatment uptake in Victoria, Australia', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101139

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Price O; Swanton R; Grebely J; Hajarizadeh B; Webb P; Peacock A; Dore GJ; Cowie BC; Vickerman P; Degenhardt L, 2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382

Marshall AD; Willing AR; Kairouz A; Cunningham EB; Wheeler A; O'Brien N; Perera V; Ward JW; Hiebert L; Degenhardt L; Hajarizadeh B; Colledge S; Hickman M; Jawad D; Lazarus JV; Matthews GV; Scheibe A; Vickerman P; Dore GJ; Grebely J; Sargsyants N; Suleymanova L; Salkic N; Simonova M; Nemeth-Blazic T; Mravcik V; Kivimets K; Salupere R; Butsashvili M; Soselia G; Makara M; Tolmane I; Jancorienė L; Stratulat S; Flisiak R; Gheorghe L; Cernat R; Lakhov A; Stanevich O; Jarcuska P; Peck-Radosavljevic M; Robaeys G; Øvrehus A; Foster G; Sutinen J; Farkkila M; Rautiainen H; Vuoti S; Nikolova D; Pawlotsky JM; Rockstroh J; Sypsa V; Papatheodoridis G; Olafsson S; Feeney E; Teti E; Seguin-Devaux C; Pocock J; Reiff S; McDougall N; Van der Valk M; Dalgard O; Tato Marinho R; Dillon J; Peters E; Bojovic K; Matičič M; Kåberg M; Bruggmann P; Healy B; Chong VH; Yi S; Tucker J; Pasaribu LR; Tanaka J; Ashley EA; Abu Hassan MR; Mohammed NS; Chan HK; Gidaagaya S; Kyi KP; Hyung Joon K; Chin B; Baladjay PC; Kao JH; Wansom T; da Cruz B; Flower B; Ehsan E; Al Mahtab M; Khandu L; Bhadoria AS; Alavi M; KC P; Hamid S; Biryukov S; Alymbaeva D; Alaei A; Bakieva S; Flichman D, 2024, 'Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions', Lancet Gastroenterology and Hepatology, 9, pp. 366 - 382, http://dx.doi.org/10.1016/S2468-1253(23)00335-7

Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B, 2024, 'Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia', Internal Medicine Journal, 54, pp. 602 - 612, http://dx.doi.org/10.1111/imj.16252

Bin Usman Shah SH; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ, 2024, 'Corrigendum to “Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales” [JHEP Reports 4 (2022)] (JHEP Reports (2022) 4(10), (S2589555922001240), (10.1016/j.jhepr.2022.100552))', Jhep Reports, 6, http://dx.doi.org/10.1016/j.jhepr.2024.101022

Lin H; Hajarizadeh B; Wood AJ; Selvarajah K; Ahmadi O, 2024, 'Postoperative Outcomes of Intracapsular Tonsillectomy With Coblation: A Systematic Review and Meta-Analysis', Otolaryngology Head and Neck Surgery United States, 170, pp. 347 - 358, http://dx.doi.org/10.1002/ohn.573

Shih STF; Stone J; Martin NK; Hajarizadeh B; Cunningham EB; Kwon JA; McGrath C; Grant L; Grebely J; Dore GJ; Lloyd AR; Vickerman P; Chambers GM, 2024, 'Scale-up of Direct-Acting Antiviral Treatment in Prisons Is Both Cost-effective and Key to Hepatitis C Virus Elimination', Open Forum Infectious Diseases, 11, pp. ofad637, http://dx.doi.org/10.1093/ofid/ofad637

Hajarizadeh B; Carson JM; Byrne M; Grebely J; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Lloyd AR; Dore GJ, 2024, 'Incidence of hepatitis C virus infection in the prison setting: The SToP-C study', Journal of Viral Hepatitis, 31, pp. 21 - 34, http://dx.doi.org/10.1111/jvh.13895

Hajarizadeh B; George J; Levy M; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate T; Matthews G, 2024, 'FRI-403 Evaluation of a novel hepatitis B DNA test from fingerstick capillary blood at the point-of-care as a tool to enhance clinical management', Journal of Hepatology, 80, pp. s776, http://dx.doi.org/10.1016/s0168-8278(24)02164-0

Shah SHBU; Valerio H; Hajarizadeh B; Matthews G; Alavi M; Dore GJ, 2023, 'Cascade of care among people with hepatitis B in New South Wales, Australia', Journal of Viral Hepatitis, 30, pp. 926 - 938, http://dx.doi.org/10.1111/jvh.13881

Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J, 2023, 'Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review', Lancet Global Health, 11, pp. e1885 - e1898, http://dx.doi.org/10.1016/S2214-109X(23)00461-8

Cheng Q; Bajis S; Cunningham E; Shih STF; Schulz M; Marshall AD; Martin NK; Miners A; Hajarizadeh B; Wiseman V; Dore GJ; Grebely J, 2023, 'Health-related quality of life among people who inject drugs in Australia', Quality of Life Research, 32, pp. 3195 - 3207, http://dx.doi.org/10.1007/s11136-023-03465-3

Razavi-Shearer DM; Gamkrelidze I; Pan CQ; Jia J; Berg T; Gray RT; Lim YS; Chen CJ; Ocama P; Desalegn H; Abbas Z; Abdallah AR; Aghemo A; Ahmadbekova S; Ahn SH; Aho I; Akarca US; Al Masri NM; Alalwan AM; Alavian SM; Al-Busafi SA; Aleman S; Alfaleh FZ; Alghamdi AS; Al-Hamoudi WK; Aljumah AA; Al-Naamani K; Al-Rifai A; AlSerkal YM; Altraif IH; Amarsanaa J; Anderson M; Andersson MI; Armstrong P; Asselah T; Athanasakis K; Baatarkhuu O; Ben-Ari Z; Bensalem A; Bessone F; Biondi MJ; Bizri ARN; Blach S; Braga WSM; Brandão-Mello CE; Brosgart CL; Brown KA; Brown RS; Bruggmann P; Brunetto MR; Buti M; Cabezas J; Casanovas T; Chae C; Chan HLY; Cheinquer H; Chen PJ; Cheng KJG; Cheon ME; Chien CH; Choudhuri G; Christensen PB; Chuang WL; Chulanov V; Cisneros Garza LE; Coffin CS; Contreras FA; Coppola N; Cornberg M; Cowie B; Cramp ME; Craxi A; Crespo J; Cui F; Cunningham CW; Dalgard O; De Knegt RJ; De Ledinghen V; Dore GJ; Drazilova S; Duberg AS; Egeonu S; Elbadri M; El-Kassas M; El-Sayed MH; Estes C; Etzion O; Farag E; Ferradini L; Ferreira PRA; Flisiak R; Forns X; Frankova S; Fung J; Gane EJ; Garcia V; Garcia-Samaniego J; Gemilyan M; Genov J; Gheorghe LS, 2023, 'Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study', Lancet Gastroenterology and Hepatology, 8, pp. 879 - 907, http://dx.doi.org/10.1016/S2468-1253(23)00197-8

Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B, 2023, 'Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston', Clinical Infectious Diseases, 77, pp. 46 - 55, http://dx.doi.org/10.1093/cid/ciad127

Shah SHBU; Alavi M; Hajarizadeh B; Matthews G; Valerio H; Dore GJ, 2023, 'Liver-related mortality among people with hepatitis B and C: Evaluation of definitions based on linked healthcare administrative datasets', Journal of Viral Hepatitis, 30, pp. 520 - 529, http://dx.doi.org/10.1111/jvh.13824

Cheng Q; Cunningham EB; Shih S; Amin J; Bruneau J; Artenie AA; Powis J; Litwin AH; Cooper C; Dalgard O; Hellard M; Bruggmann P; Marks P; Lacombe K; Stedman C; Read P; Hajarizadeh B; Dunlop AJ; Conway B; Feld JJ; Dore GJ; Grebely J; Dore G; Crawford S; Swan T; Byrne J; Coordinating Centre—Amanda Erratt ML; Marks P; Shaw I; Siriragavan S; Quiene S; Petoumenos K; Schmid P; Castro E; Moriggia A; Daulouede JP; Fraser C; Feld J; Gane E; Matthews G; Kronborg I; Shaw D; Norton B; Thurnheer MC; Weltman M; Read P; Dillon J; Kessler S; Knapp C; Oprandi L; Messina P; Pantic M; Le Cam M; Maitre C; Andreassen J; Melkeraaen I; Tollefsen MM; Pagarigan H; Milne R; Mason K; Kaznowski D; Zou L; Bouchard R; Kotsoros B; Muir M; Milloy J; Oliver V; Noonan T; Sevehon A; Hazelwood S; Hall M; Hagenauer M; Liddle R; Ferguson C; Agyemang L; Patel H; Soloway I; Cerocchi O; Lacalamita M; Fragomeli V; Gilliver R; Lothian R; Cleary S; Johnston L; Middleton S; D'Amico R; McGovern B; Anderson J; Zhong Z; Keane F; Tatsch F; Brainard D; McHutchison J, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26, pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016

Carson JM; Barbieri S; Matthews GV; Dore GJ; Hajarizadeh B, 2023, 'Corrigendum to ‘National trends in retreatment of HCV due to reinfection or treatment failure in Australia’ (J Hepatol [2023] 260–270) (Journal of Hepatology (2023) 78(2) (260–270), (S016882782203118X), (10.1016/j.jhep.2022.09.011))', Journal of Hepatology, 78, pp. 1084, http://dx.doi.org/10.1016/j.jhep.2023.02.020

Back to profile page